knowledge -WSS

knowledge

author：Wikipedia 2025-09-03 03:28:29 - browse：83

A hospital bed is seen in a COVID-19 unit at Providence Holy Cross Medical Center in the Mission Hills section of Los Angeles, Nov. 19, 2020. Roughly 84 million people are covered by Medicaid, the government-sponsored program that's grown by 20 million people since January 2020, just before the coronavirus pandemic hit. Now, as states begin checking everyone’s eligibility for Medicaid for the first time in three years, as many as 14 million people could lose access to that coverage. – politics and policy coverage from STAT — Jae C. Hong/AP

Roughly 7.7% of Americans didn’t have any health insurance as of this past March — a “record low” uninsured rate, according to the latest health insurance survey from the Centers for Disease Control and Prevention.

However, that uninsured rate — which still translated to more than 25 million Americans with no health coverage — is almost certainly higher now. That’s because the data don’t include the millions of low-income Americans who have lost the Medicaid coverage they gained during the pandemic.

Congress passed a law in March 2020 that gave states extra federal Medicaid funds, but states could only receive that money if they agreed to loosen eligibility requirements and keep more people enrolled. Changes in income or unfiled paperwork were no longer valid reasons to remove someone from Medicaid while the public health emergency was in effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Neuroscience startup Neumora files for IPO

knowledge

hotspot

WSS

AstraZeneca bets AAV gene therapy will still deliver the goods

Fentanyl is making it harder to start addiction treatment

In science, is the line between industry and academia shifting?

At flashy new research hub, AstraZeneca lays out ambitious growth goals

What AAP's gender

CDC advisory panel says seniors 'may' get RSV vaccine

explore

knowledge

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Winners, losers from Medicare’s list of drugs subject to price talks

Anesthesiologist group: stop taking Ozempic before surgery

ASCO eve: Let’s set the table for this year's meeting

As demand for Covid shots wanes, Moderna seeks its next success

Radiation, mainstay of cancer treatment, begins a fade

Medicare details structure of new drug price negotiation program

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Psychedelics group wrestles with new pharma identity

Digital health: a case of mistaken identity

explore

Scrutiny of post

ASCO eve: Let’s set the table for this year's meeting

Digital health: a case of mistaken identity

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

entertainment

knowledge

hotspot

focus